Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$693M |
| 2 |
Reddit
RDDT
|
+$650M |
| 3 |
Applovin
APP
|
+$366M |
| 4 |
Samsara
IOT
|
+$356M |
| 5 |
Dollar General
DG
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.81B |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$988M |
| 3 |
Workday
WDAY
|
+$978M |
| 4 |
Spotify
SPOT
|
+$777M |
| 5 |
Elastic
ESTC
|
+$699M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.2% |
| 2 | Technology | 25.57% |
| 3 | Communication Services | 19.74% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Teradyne
TER
$59.3B
| $28.1K | ﹤0.01% |
312
| – | – |
|
252
CRH
CRH
$66.8B
| $21.8K | ﹤0.01% |
238
-104
| -30% | -$9.49K |
|
253
Unilever
UL
$136B
| $20.5K | ﹤0.01% |
298
-70
| -19% | -$4.91K |
|
254
Hubbell
HUBB
$27.2B
| $17.6K | ﹤0.01% |
43
| – | – |
|
255
United Rentals
URI
$72.4B
| $16.6K | ﹤0.01% |
22
| – | – |
|
256
Veeva Systems
VEEV
$37.4B
| $12.1K | ﹤0.01% |
42
| – | – |
|
257
Rio Tinto
RIO
$164B
| $11.7K | ﹤0.01% |
200
-119
| -37% | -$7.03K |
|
|
NVO
258
Novo Nordisk
NVO
$209B
| $8.97K | ﹤0.01% |
130
-46
| -26% | -$3.13K |
|
259
TotalEnergies
TTE
$190B
| $7.86K | ﹤0.01% |
128
+70
| +121% | +$4.15K |
|
260
AB InBev
BUD
$165B
| $7.76K | ﹤0.01% |
113
+13
| +13% | +$873 |
|
261
UBS Group
UBS
$176B
| $5.82K | ﹤0.01% |
+172
| New | +$5.32K |
|
262
Li Auto
LI
$12.7B
| $3.04K | ﹤0.01% |
112
| – | – |
|
263
Genmab
GMAB
$19.5B
| $248 | ﹤0.01% |
12
-42
| -78% | -$862 |
|
264
Ares Capital
ARCC
$14.4B
| – | – |
-753,649
| Closed | -$16.7M |
|
265
Blackstone Secured Lending
BXSL
$5.72B
| – | – |
-505,229
| Closed | -$16.3M |
|
|
CLLS
266
Cellectis
CLLS
$285M
| – | – |
-139,047
| Closed | -$172K |
|
267
Charles River Laboratories
CRL
$12.8B
| – | – |
-49
| Closed | -$7.38K |
|
268
Cemex
CX
$16.3B
| – | – |
-6,150,122
| Closed | -$34.5M |
|
269
Energy Recovery
ERII
$443M
| – | – |
-1,099,276
| Closed | -$17.5M |
|
|
270
Elastic
ESTC
$7.81B
| – | – |
-7,843,557
| Closed | -$699M |
|
271
EverQuote
EVER
$906M
| – | – |
-221,286
| Closed | -$5.8M |
|
272
Golub Capital BDC
GBDC
$3.42B
| – | – |
-548,319
| Closed | -$8.3M |
|
273
Installed Building Products
IBP
$6.49B
| – | – |
-36,482
| Closed | -$6.26M |
|
|
JMIA
274
Jumia Technologies
JMIA
$767M
| – | – |
-8,629,656
| Closed | -$18.6M |
|
|
MTLS
275
Materialise
MTLS
$396M
| – | – |
-83,119
| Closed | -$409K |
|
Similar funds
Baillie Gifford & Co's Q2 2025 Portfolio in Review
As of Q2 2025, Baillie Gifford & Co held 284 positions worth $134B, up 17% from $115B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Baillie Gifford & Co withdrew a net $6.67B in Q2 2025, closing 20 positions and reducing 175 holdings. Its most notable exit was BeOne Medicines Ltd, an estimated $988M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in Tempus AI worth $768M.
- Baillie Gifford & Co's largest Q2 2025 buy was Tempus AI: 12,094,029 shares worth $768M.
- Baillie Gifford & Co added most to Reddit in Q2 2025, an estimated $650M increase.
- Baillie Gifford & Co's biggest Q2 2025 reduction was Shopify, cutting an estimated $1.81B.
- Baillie Gifford & Co fully exited BeOne Medicines Ltd in Q2 2025, selling an estimated $988M.
- Baillie Gifford & Co's ten largest holdings make up 46% of its $134B portfolio in Q2 2025.
- Baillie Gifford & Co opened 19 new positions and closed 20 in Q2 2025.
- Baillie Gifford & Co's portfolio value rose 17% quarter-over-quarter to $134B.
Based on Baillie Gifford & Co's 13F filing for Q2 2025, filed 6 Aug 2025.